Statement by Press Secretary Karine Jean-Pierre on the Southern District of Ohio's Decision on Medicare Drug Price Negotiation

For decades, Big Pharma blocked Medicare from negotiating lower drug prices for seniors, while drug companies made record profits. President Biden and Congressional Democrats finally changed that when they passed the Inflation Reduction Act – while every single Republican in Congress sided with Big Pharma to keep health care costs high for millions of families.

Today's ruling from the Southern District of Ohio affirms that Medicare will move forward with negotiating lower prices for millions of seniors. And, the Biden-Harris Administration won't stop fighting for what we know to be true: that nothing in the Constitution prohibits Medicare from negotiating drug prices.

Because of President Biden's Inflation Reduction Act and this program, millions of people with Medicare will continue to see prescription drug costs go down for some of the costliest drugs that treat common conditions like heart failure, blood clots, diabetes, arthritis, and more.

There is no reason why Americans should be forced to pay two to three times more for their prescription drugs that any other developed nation. President Biden and his Administration will continue fighting to lower health care costs for American families, no matter how many challenges Republicans and Big Pharma put in our way.